| 2013-12 | Ebastine의 약동학에 미치는 Telmisartan의 영향 | 백상훈; 박선경; 장유정; 임미선; 강원구 |
| 2012-02 | Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics | 임미선; Lee HW[Lee HW]; Lee J[Lee J]; Jegal MY[Jegal MY]; Kim DW[Kim DW]; Lee WK[Lee WK]; Jang IJ[Jang IJ]; Shin JG[Shin JG]; Yoon YR[Yoon YR] |
| 2011-08 | In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms | 임미선; H. W. Lee[H. W. Lee]; D. W. Kim[D. W. Kim]; P. B. Phapale[P. B. Phapale]; J. Park[J. Park]; J. J. Seo[J. J. Seo]; K. M. Park[K. M. Park]; Y. -K. Park[Y. -K. Park]; Y. -R. Yoon[Y. -R. Yoon] |
| 2013-03 | Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients | 현명수; Y.-R. Yoon[Y.-R. Yoon]; S. J. Seong[S. J. Seong]; M. Lim[M. Lim]; S. K. Sohn[S. K. Sohn]; J. H. Moon[J. H. Moon]; S.-J. Oh[S.-J. Oh]; B. S. Kim[B. S. Kim]; H. M. Ryoo[H. M. Ryoo]; 김민경; 임미선; S. J. Seong[S. J. Seong]; S. K. Sohn[S. K. Sohn]; J. H. Moon[J. H. Moon]; S.-J. Oh[S.-J. Oh]; B. S. Kim[B. S. Kim]; H. M. Ryoo[H. M. Ryoo]; J. S. Chung[J. S. Chung]; Y. D. Joo[Y. D. Joo]; S. M. Bang[S. M. Bang]; C. W. Jung[C. W. Jung]; D. H. Kim[D. H. Kim]; S. Y. Park[S. Y. Park]; S. S. Yoon[S. S. Yoon]; I. Kim[I. Kim]; H. G. Lee[H. G. Lee]; J. H. Won[J. H. Won]; Y. H. Min[Y. H. Min]; J. W. Cheong[J. W. Cheong]; J. S. Park[J. S. Park]; K. S. Eom[K. S. Eom]; M. S. Hyun[M. S. Hyun]; M. K. Kim[M. K. Kim]; H. Kim[H. Kim]; M. R. Park[M. R. Park]; J. Park[J. Park]; C. S. Kim[C. S. Kim]; H. J. Kim[H. J. Kim]; Y. K. Kim[Y. K. Kim]; E. K. Park[E. K. Park]; D. Y. Zang[D. Y. Zang]; D. Y. Jo[D. Y. Jo]; H. W. Lee[H. W. Lee]; Y.-R. Yoon[Y.-R. Yoon] |
| 2010-08 | Liquid chromatography-tandem mass spectrometry quantification of levosulpiride in human plasma and its application to bioequivalence study | 임미선; Prasad B. Phapale[Prasad B. Phapale]; 이혜원[이혜원]; 성숙진[성숙진]; 김은희[김은희]; 박정현[박정현]; 이미란[이미란]; 황성규[황성규]; 윤영란[윤영란] |
| 2013-12 | Pattern Recognition Analysis for Hepatotoxicity Induced by Acetaminophen Using Plasma and Urinary H-1 NMR-Based Metabolomics in Humans | 임미선; Kim JW[Kim JW]; Sung Ha Ryu[Sung Ha Ryu]; Siwon Kim[Siwon Kim]; Hae Won Lee[Hae Won Lee]; Sook Jin Seong[Sook Jin Seong]; Suhkmann Kim[Suhkmann Kim]; Young-Ran Yoon[Young-Ran Yoon]; Kyu-Bong Kim[Kyu-Bong Kim] |
| 2012-02 | Pharmacokinetics of a New Once-Daily Controlled-Release Formulation of Aceclofenac in Korean Healthy Subjects Compared with Immediate-Release Aceclofenac and the Effect of Food A Randomized, Open-Label, Three-Period, Crossover, Single-Centre Study | 임미선; Bae SK[Bae SK]; Kim SH[Kim SH]; Lee HW[Lee HW]; Seong SJ[Seong SJ]; Shin SY[Shin SY]; Lee SH[Lee SH]; Yoon YR[Yoon YR]; Lee HJ[Lee HJ] |
| 2013-04 | Pharmacometabolomic Approach to Predict QT Prolongation in Guinea Pigs | 강원구; 박정현[박정현]; 노금한; 이해원[이해원]; 임미선; 성숙진[성숙진]; 서정주[서정주]; 김은정[김은정]; 윤영란[윤영란] |
| 2014-12 | Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study | 임미선; 박성민[박성민]; 이주미[이주미]; 성숙진[성숙진]; 박종광[박종광]; 권미리[권미리]; 이혜원 [이혜원 ]; 윤영란[윤영란]; 양동현[양동현]; 권광일[권광일]; 한승훈[한승훈] |
| 2012-07 | Population Pharmacokinetic/Pharmacodynamic Modeling of Clopidogrel in Korean Healthy Volunteers and Stroke Patients | 이주미[이주미]; 황용하[황용하]; 강원구; 성숙진[성숙진]; 이해원[이해원]; 임동석[임동석]; 손동렬[손동렬]; 한성훈[한성훈]; 윤영란[윤영란]; 임미선 |
| 2012-08 | Quantile Normalization Approach for Liquid Chromatography-Mass Spectrometry-based Metabolomic Data from Healthy Human Volunteers | 임미선; 이주미[이주미]; 박정현[박정현]; 성숙진[성숙진]; 서정주[서정주]; 박성민[박성민]; 이혜원[이혜원]; 윤영란[윤영란] |
| 2010-06 | Rapid determination of finasteride in human plasma by UPLC-MS/MS and its application to clinical pharmacokinetic study | 임미선; Prasad B. Phapale[Prasad B. Phapale]; 이혜원[이혜원]; 김은희[김은희]; 김성두[김성두]; 박정현[박정현]; 이미란[이미란]; 황성규[황성규]; 윤영란[윤영란] |
| 2013-03 | Rapid determination of sumatriptan in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetic study | 임미선; 서정주[서정주]; 박정현[박정현]; 배민호[배민호]; 성숙진[성숙진]; 이주미[이주미]; 박성민[박성민]; 이혜원 [이혜원 ]; 윤영란[윤영란] |
| 2012-08 | Single-dose pharmacokinetics and dose proportionality of intravenous pazufloxacin mesilate in healthy Korean volunteers | 임미선; 이주미[이주미]; 성숙진[성숙진]; 박성민[박성민]; 박정현[박정현]; 서정주[서정주]; 이혜원[이혜원]; 윤영란[윤영란] |
| 2011-11 | THE EFFECT OF AGE ON THE PHARMACOKINETICS OF FIMASARTAN (BR-A-657). | 임미선; Lee HW[Lee HW]; Seong SJ[Seong SJ]; Lee J[Lee J]; Park J[Park J]; Seo J[Seo J]; Cho J[Cho J]; Yu K[Yu K]; Yoon Y[Yoon Y] |
| 2013-12 | 건강한 남성 자원자에서 탐스로신의 공복 투여 시항정상태의 약동학적 특성 연구 | 임미선; 성숙진[성숙진]; 이혜원[이혜원]; 이주미[이주미]; 김은희[김은희]; 박성민[박성민]; 권미리[권미리]; 윤영란[윤영란] |
